OR WAIT null SECS
© 2022 MJH Life Sciences and BioPharm International. All rights reserved.
© 2022 MJH Life Sciences™ and BioPharm International. All rights reserved.
Robin A. Heller-Harrison is the associate director and the corresponding author in the cell and molecular sciences group in the department of Drug Substance Development at Wyeth Biopharma
By considering stability as part of the cell line selection and cell banking paradigm, we can ensure that instability problems are not observed during clinical or commercial manufacturing.